InvestorsHub Logo
icon url

Play4keeps2

05/07/19 9:52 AM

#139271 RE: Stockman1010101 #139270

I said "may" be a world player. We'll know more when fins drop, but I expect ARYC to be a top competitor in their field. All MO.
icon url

stockbuster

05/07/19 9:54 AM

#139272 RE: Stockman1010101 #139270

That's because they are lieing to everyone. Go to arrayit on Twitter and see what someone posted to their 27.9 million production run tweet. Spiriplex is the patent holder of the allergy testing. Arrayit has nothing to do with spiriplex. If you dont believe me then go look because the poster put up the patent application submitted by spiriplex of the allergy testing. It's there in black and white and clear as day. Arrayit is playing off that. The email responses from spiriplex states they have no dealings with Arrayit Corp. And if any of you think its bs then do me a favour and let's see arrayits patent submission. This is why they are not releasing the fins because people that actually do dd will find that Arrayit is not telling the truth. Arrayit also tweeted on April 9th that they started a 27.9 million production run. Yesterday they tweeted 27.9 million production run. 2 tweets are the same only they changed a few words. Go check it.
icon url

okwife

05/07/19 11:14 AM

#139310 RE: Stockman1010101 #139270

WHY ISN'T THE IRS ALL OVER THIS CO. FOR NOT REPORTING THEIR INCOME?
icon url

whippinsaw

05/08/19 3:40 PM

#139566 RE: Stockman1010101 #139270

After the theranos debalacle, investors left the blood testing market, leaving arrayit holding a bag
Years later with a push from the fda for precision medicine, arrayit is back in the game.